HMP Global Acquires Drug Channels Institute

January 4, 2024

HMP Global has entered into a definitive agreement to acquire Drug Channels Institute (DCI), a provider of pharmaceutical market intelligence and analysis. The acquisition will fold DCI into HMP Market Access Insights to create a new market intelligence division, expanding HMP Global's research capabilities and services for clients across the pharmaceutical ecosystem.

Buyers
HMP Global
Targets
Drug Channels Institute
Location
Pennsylvania, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.